BRIDGEWATER, N.J. - Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) announced Tuesday that the U.S. Food and Drug Administration has approved its albuterol sulfate inhalation aerosol, a generic equivalent ...

Friday’s announcement is the latest in a series of events in which Trump has boasted of securing cooperation from drug makers ...

A U.S. analysis found inhalers for asthma and COPD generated nearly 25 million metric tons of CO₂ emissions between 2014 and ...

This shift matters because the pharmaceutical industry carries material weight. The sector is estimated to be responsible for ...

More than 30 people with dangerous but treatable ailments — infections, obstructed bowels and asthma attacks — died in the past decade.

Amneal Pharmaceuticals recently received U.S. FDA approvals for its generic versions of RESTASIS® (cyclosporine ophthalmic emulsion 0.05%) and PROAIR® HFA (albuterol sulfate inhalation aerosol 90 mcg) ...

On May 12, 2025, President Trump signed an Executive Order titled: "Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients" directing the Administration to take numerous actions ...

President Donald Trump announced nine new agreements with major pharmaceutical companies aimed at lowering prescription drug prices for Americans. The White House said the agreements ...

From generics to branded drugs, Jefferies’ latest pharma calls spotlight Alkem, Lupin, Sun Pharma, Torrent, and Zydus as India’s key growth stories.

Jamie achieved a level of fame around a decade ago as a contestant on RTE’s The Voice of Ireland. Although he was mentored by ...